Drug Delivery Nanoparticles Formulation

• Carbon-based Nanocages Production
• Exosomes Production
• Metallic Nanoparticles Production
• Nanocages Production
• Polymeric Nanoparticles Production
• Protein-based Nanoparticles Production
• Liposomes Production
• Living Cell-Based Drug Delivery Systems
• Peptide-Based Drug Delivery Systems
• Viral Vector-Based Delivery System

CD Bioparticles’ services with customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms can help you to solve:

The challenges you might meet:

• Drugs/Active pharmaceutical ingredient (API) which are hard to be dispersed or dissolved in different solvent systems
• Limited options for drug/API encapsulation into different formats (size, structure, crystallization)
• Limited options of drug/API loading carriers for different types of drugs/API
• Low specificity of the targeting
• High dosage required for treatment
• High side-effect of the toxic chemotherapeutic agents
• Tedious materials synthesis, modification, and production

Figure 1. Nanoparticle types that can be custom developed.

Key features:

• Excellular vesicle/Exosomes Production

  • Exosome-Mimetic Nanovesicles Production

  • Mesenchymal Stem Cell (MSC) Exosomes Biological Function

• Liposomes Production

  • Conventional Liposomes Production

  • Immunoliposomes (Ligand-Targeted Liposomes) Production

  • PEGylated Liposomes Production

  • Pharmacosomes Production

  • Solid Lipid Nanoparticle Production

  • Transfersomes and Ethosomes Production

  • Cationic Nanoemulsions Production

  • Lipid Nanoparticle Production

  • Nanostructured Lipid Carriers Production

• Nanocages Production

• Nanocapsules Production

• Microcapsule Production

• Micelles Productions

• Metallic Nanoparticles Production

• Carbon-based Nanocages Production

• Cyclodextrin production

• Polymeric Nanoparticles Production

• Protein-based Nanoparticles Production

• Molecular Motor production

• Living Cell-Based Drug Delivery Systems

• Peptide-Based Drug Delivery Systems

• Viral Vector-Based Delivery System

  • Adeno-Associated Virus Vectors

  • Adenovirus Vectors

  • HSV Vectors

  • Lentiviral Vectors

  • Retroviral Vectors

  • VSV Vectors

Key benefits:

• Wide coverage of the biocompatible drug-delivery system for different dosage forms for different administration routes, such as oral formulation, injection formulation, cutaneous formulation, mucosal formulation, and inhalation formulation.
• Drug-oriented, customized drug-delivery system production and formulation improves the delivery efficiency of the drugs, such as small molecules, nucleic acids, or peptides
• Improving the drug/API absorption/penetration/targeting, as well as the stability
• Ready-to-use drug-delivery systems
• Post-loadable drug-delivery systems simplifying your loading process, improving your API loading yield in a controllable way
• Adaptable building blocks for customized formulation
• Analytical platforms cover from drug-delivery system fabrications to in-vitro and in-vivo tests
• From pre-formulation to GMP process, promising the quality of products

Application candidates:

• Nanoparticles with low targeting efficiency and low targeting specificity
• Cell specific, or tissue specific targeted delivery
• Non-invasive therapy or minimally invasive therapy
• Programmable delivery
• Drugs/API delivery with different administration routes